Anemia of malignancy

E. P. Frenkel; R. L. Bick; C. J. Rutherford

doi:10.1016/S0889-8588(05)70373-7

Anemia of malignancy

E. P. Frenkel, R. L. Bick, C. J. Rutherford

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Anemia is a common association of malignant disease. It may be the first diagnostic clue to an underlying malignant disease, it may contribute to the patient's symptoms from the disease, and it may affect treatment decisions. It is important to recognize that a number of underlying mechanisms may contribute to the anemia, and to exclude those that are treatable. The recognition that tumor-associated cytokine production is a major factor in the anemia of malignancy, and that recombinant EPO can overcome this suppression, are major steps forward.

Original language	English (US)
Pages (from-to)	861-874
Number of pages	14
Journal	Hematology/Oncology Clinics of North America
Volume	10
Issue number	4
DOIs	https://doi.org/10.1016/S0889-8588(05)70373-7
State	Published - 1996

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/S0889-8588(05)70373-7

Cite this

@article{d05351f60b3f499697c9a25d61e65db9,

title = "Anemia of malignancy",

abstract = "Anemia is a common association of malignant disease. It may be the first diagnostic clue to an underlying malignant disease, it may contribute to the patient's symptoms from the disease, and it may affect treatment decisions. It is important to recognize that a number of underlying mechanisms may contribute to the anemia, and to exclude those that are treatable. The recognition that tumor-associated cytokine production is a major factor in the anemia of malignancy, and that recombinant EPO can overcome this suppression, are major steps forward.",

author = "Frenkel, {E. P.} and Bick, {R. L.} and Rutherford, {C. J.}",

year = "1996",

doi = "10.1016/S0889-8588(05)70373-7",

language = "English (US)",

volume = "10",

pages = "861--874",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Anemia of malignancy

AU - Frenkel, E. P.

AU - Bick, R. L.

AU - Rutherford, C. J.

PY - 1996

Y1 - 1996

N2 - Anemia is a common association of malignant disease. It may be the first diagnostic clue to an underlying malignant disease, it may contribute to the patient's symptoms from the disease, and it may affect treatment decisions. It is important to recognize that a number of underlying mechanisms may contribute to the anemia, and to exclude those that are treatable. The recognition that tumor-associated cytokine production is a major factor in the anemia of malignancy, and that recombinant EPO can overcome this suppression, are major steps forward.

AB - Anemia is a common association of malignant disease. It may be the first diagnostic clue to an underlying malignant disease, it may contribute to the patient's symptoms from the disease, and it may affect treatment decisions. It is important to recognize that a number of underlying mechanisms may contribute to the anemia, and to exclude those that are treatable. The recognition that tumor-associated cytokine production is a major factor in the anemia of malignancy, and that recombinant EPO can overcome this suppression, are major steps forward.

UR - http://www.scopus.com/inward/record.url?scp=0029899899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029899899&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(05)70373-7

DO - 10.1016/S0889-8588(05)70373-7

M3 - Article

C2 - 8811306

AN - SCOPUS:0029899899

SN - 0889-8588

VL - 10

SP - 861

EP - 874

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

IS - 4

ER -

Anemia of malignancy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this